Genes useful for diagnosing and monitoring inflammation related disorders
Described herein is a system for monitoring gene expression for diagnosing and monitoring inflammation disorders, and for monitoring gene expression in inflammation disorders in response to a particular drug treatment regimen. This system for detecting nucleic acid expression in a body fluid uses an isolated polynucleotide to detect expression of a nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NO: 5; SEQ ID NO:11; SEQ ID NO:17; and SEQ ID NO: 23. These nucleic acids are differentially expressed in body fluid in an individual with a disease criterion for a disease as listed in Table 1 as compared to an individual without the disease criterion.
1. A method for determining the likelihood of a human patient to reject a cardiac transplant comprising detecting the level of a RNA that encodes SEQ ID NO: 24 in a blood sample from said patient and determining that said patient is likely to reject said cardiac transplant when the level of said RNA that encodes SEQ ID NO: 24 is increased relative to the mean level of said RNA that encodes SEQ ID NO: 24 in quiescent samples.
2. The method of claim 1 further comprising isolating said RNA from said patient prior to detecting.
3. The method of claim 2 wherein said RNA is detected by PCR.
4. The method of claim 2 wherein said RNA is detected by hybridization.
5. The method of claim 2 wherein said RNA is detected by hybridization to an oligonucleotide.
6. The method of claim 5 wherein said oligonucleotide comprises DNA, RNA, cDNA, PNA, genomic DNA, or synthetic oligonucleotides.